DEVELOPMENT, CHARACTERIZATION AND IN-VITRO RELEASE KINETIC STUDIES OF IBANDRONATE LOADED CHITOSAN NANOPARTICLES FOR EFFECTIVE MANAGEMENT OF OSTEOPOROSIS

Authors

  • S. PATHAK Department of Chemistry, Dr. H. S. Gour Central University, Sagar (M.P.), India 470003
  • S. P. VYAS Department of Pharmaceutical Sciences, Dr. H. S. Gour Central University, Sagar (M. P.), India 470003
  • A. PANDEY Department of Chemistry, Dr. H. S. Gour Central University, Sagar (M.P.), India 470003

DOI:

https://doi.org/10.22159/ijap.2021v13i6.42697

Keywords:

Bisphosphonate, Bone mineral density (BMD), Ion gelation, Nanoparticle, Osteoporosis, Release kinetics

Abstract

Objective:  The objective of the present study was to develop, optimize, and evaluate Ibandronate- sodium loaded chitosan nanoparticles (Ib-CS NPs) to treat osteoporosis.

 Methods: NPs were prepared by the Ionic gelation method and optimized for various parameters such as the effect of concentration of chitosan, sodium tripolyphosphate (TPP), and pH effect on particle size polydispersity index (PDI), zeta potential, and entrapment efficiency. The prepared nanoparticles were characterized using particle size analyzer (DLS), transmission electron microscopy (TEM), scanning electron microscopy (SEM), and Fourier-Transform Infrared spectroscopy (FTIR). 

Results: Formulated NPs were obtained in the average nano size in the range below 200 nm in TEM, SEM, and DLS studies. The particle size and encapsulation efficiency of the optimized formulation were 176.1 nm and 63.28%, respectively. The release profile of NPs was depended on the dissolution medium and followed the First -order release kinetics.

Conclusion: Bisphosphonates are the most commonly prescribed drugs for treating osteoporosis in the US and many other countries, including India. Ibandronate is a widely used anti-osteoporosis drug, exhibits a strong inhibitory effect on bone resorption performed by osteoclast cells. Our results indicated that Ibandronate sodium-loaded chitosan nanoparticles provide an effective medication for the treatment of osteoporosis.

Downloads

Download data is not yet available.

References

Kawalkar A K. A Comprehensive Review on Osteoporosis. Journal of Trauma & Orthopaedics

; 9: 3-12.

Rapp K, Rothenbacher D, Magaziner J. Risk of nursing home admission after femoral fracture

compared with stroke, myocardial infarction, and pneumonia. J Am Med Dir Assoc 2015; 16:

-5.

Dhaliwala R, Mikhailb M, Userab G, et al. The relationship of Physical performance and

Osteoporosis prevention with vitamin D in older African Americans (PODA); Contemporary

Clinical Trials 2018; 65:39–45.

Weaver CM, Alexander DD, Boushey CJ, et al. Calcium plus vitamin D supplementation and risk of fractures. Osteoporosis Int. 2016; 2: 367-376.

Deluca L, Chiminazzo A, Sperni L, Strukul G, and Scarso A. Pyrrolidine Containing Bisphosphonates as Potential Anti Resorption Bone Drugs. Chemistry - A European Journal 2017; 23: 3222-96.

Akgun B, Avci D. Synthesis and evaluations of bisphosphonate-containing monomers for dental materials. J Polym Sci A Polym Chem 2012; 50: 4854–63.

Reginster JY, et al. Oral and Intravenous Ibandronate in the Management of Postmenopausal Osteoporosis: A Comprehensive Review. Current Pharmaceutical Design 2005; 11: 3711-28.

Shukla J, et al. CaCO3 Microparticle containing Ibandronate-Alginate beads for improved adherence to Bisphosphonate oral therapy: Formulation and In vitro Release. Int J Pharm 2013; 3: 340-7.

Gu W, Wu C, Chen J, Xiao Y. Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. Int J Nanomedicine 2013; 8: 2305-17.

Roy SG, et al. A review on chitosan nanoparticles applications in drug delivery. Journal of Pharmacognosy and Phytochemistry 2018; SP6: 01-04.

Sacco P, Brun F, Donati I, et al. On the correlation between the microscopic structure and properties of phosphate-cross-linked chitosan gels. ACS Appl Mater Interfaces 2018.

Iswanti FC, et al. Preparation, characterization, and evaluation of chitosan-based nanoparticles as CpG ODN carriers. Biotechnology and Biotechnological equipment 2019; 33: 390–96.

Pimple S, et al. Formulation development and compatibility study of ibandronate sodium injection (3mg/3mL). J. Chem. Pharm. Res 2014; 6: 400-07.

Mithal A, Bansal B, Kyer CS, Ebeling P. The Asia-Pacific regional audit epidemiology, costs, and burden of osteoporosis in India 2013: a report of International Osteoporosis Foundation. Indian J Endocrinol Metab 2014; 18: 449-54.

Leslie WD. Clinical review: ethnic differences in bone mass clinical implications. J Clin. Endocrinal Metab 2012; 97: 432-40.

Khadilkar AV, Mandlik RM. Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Women’s Health 2015; 7: 841-50.

Divya K, Vijayan S, George TK, Jisha M. Antimicrobial properties of chitosan nanoparticles: mode of action and factors affecting activity. Fibers Polym 2017; 18: 221–30.

Huang YC, Li RY. Preparation and characterization of antioxidant nanoparticles composed of chitosan and fucoidan for antibiotics delivery. Mar Drugs 2014; 12: 4379–98.

Olivera S, Muralidhara HB, Venkatesh K, Guna VK, Gopalakrishna K, Kumar Y. Potential applications of cellulose and chitosan nanoparticles/composites in wastewater treatment: a review. Carbohydr Polym 2016; 153: 600–18.

Bohrey S, Chourasiya V and Pandey A. Polymeric Nanoparticles Containing Diazepam: Preparation, Optimization, Characterization, In-Vitro Drug Release and Release Kinetic Study. Nano Convergence 2016; 3:1-7.

Chourasiya V, Bohrey S, Pandey A, Polymeric nanoparticles containing ramipril Using biodegradable polymer: preparation, Optimisation by 23 factorial design, Characterisation and in vitro drug release kinetics, Oxidation Communications, 2017; 40: 1355–66.

Cosman F, De Beur S, LeBoff M, et al. Clinician’s guide to prevention and treatment of osteoporosis, Osteoporos Int. 2014; 25: 2359–81.

Inta O, Yoksan R, Limtrakul J. Hydrophobically modified chitosan: A bio-based material for antimicrobial active film. Materials Science and Engineering 2014; C (42): 569–577.

Olivera S, Muralidhara HB, Venkatesh K, Guna VK, Gopalakrishna K, Kumar Y. Potential applications of cellulose and chitosan nanoparticles/composites in wastewater treatment: a review. Carbohydr Polym 2016; 153: 600–18.

Jeon SJ, Oh M, Yeo WS, Galvao KN, Jeong KC. Underlying mechanism of antimicrobial activity of chitosan microparticles and implications for the treatment of infectious diseases. PLOS ONE 2014; 9: 27-3.

Rampino A, et al. Chitosan nanoparticles: Preparation, size evolution and stability. International Journal of Pharmaceutics 2013; 455: 219– 28.

Grillo R, Chitosan/tripolyphosphate nanoparticles loaded with paraquat herbicide: an environmentally safer alternative for weed control. J Hazard Mater 2014; 278:163–71.

Gautam L, Sharma R, Shrivastava P, Vyas S, Vyas SP. Development and Characterization of Biocompatible Mannose Functionalized Mesospheres: an Effective Chemotherapeutic Approach for Lung Cancer Targeting. AAPS PharmSciTech. 2020; 21:1-3.

K. H. Ramteke : Mathematical models of drug dissolution: A review. sch.Acad.J.Pharm 2014; 3: 388-96.

Rasad MK, Alhamza HK, Jamal AA. Development of sustained release Alogliptin tablets using a multiparticulates system made of Bentonite. Int J App Pharm, 2021; 13: 68-73.

Tripathi SK, Patel B, Shukla S, Pachouri C, Pathak S and Pandey A. Donepezil loaded PLGA Nanoparticles, from Modified Nano-Precipitation, an Advanced Drug Delivery System to treat Alzheimer Disease. NCRAPS 2020; 1849(2021): 012001.

Calvo P, et al. Chitosan and chitosan: ethylene oxide-propylene oxide block copolymer NPs as novel carriers for proteins and vaccines. Pharm Res 1997; 14: 1431–6.

Iswandana R, et al. Formulation of chitosan tripolyphosphate-tetrandrine beads using ionic gelation method: in vitro and in vivo evaluation. Int J Appl Pharm 2017; 9: 109-15.

Severino PC, et al. Chitosan Cross-Linked Pentasodium Tripolyphosphate Micro/Nanoparticles Produced by Ionotropic Gelation. Sugar Tech 2014.

Sailaja AK, Amreshwar P, Chakravarty P. Different techniques used for the preparation of nanoparticles using natural polymers and their application. Int J Pharm Sci 2011; 3: 45-50.

Othman N, et al. Synthesis and Optimization of Chitosan Nanoparticles Loaded with L-Ascorbic Acid and Thymoquinone. Nanomaterials 2018; 8: 920.

Saini D, et al. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis. Drug Delivery ( Informa Healthcare USA) 2015; 22: 823–36.

Weng J, et al. In Vitro Release Study of the Polymeric Drug Nanoparticles: Development and Validation of a Novel Method. Pharmaceutics 2020; 12: 732.

Y. Zambito et al. Is dialysis a reliable method for studying drug release from nanoparticulate systems?—A case study. International Journal of Pharmaceutics 2012; 434: 28–34.

Reddy GM, Bhaskar BV, Reddy PP, et al. Structural identification and characterization of potential impurities of pantoprazole sodium. J Pharm Biomed Anal. 2007;45(2):201–10.

Hanif M, et al. Enhancement of Oral Bioavailability of Ibandronate Through Gastroretentive Raft

Forming Drug Delivery System: In Vitro and In Vivo Evaluation. International Journal of Nanomedicine 2020;15.

Karavas E, Georgarakis M, Docoslis A. Bikiaris D. Combining SEM, TEM, and micro-Raman

techniques to differentiate between the amorphous molecular level dispersions and

nanodispersions of a poorly-water soluble drug within a polymer matrix. Int. J. Pharm 2007; 340:

-83.

Cont R D, A physiologically oriented mathematical model for the description of in vivo drug

release and absorption. ADMET and DMPK, 2014; 2: 80-97.

Dubey S, Vyas SP, Emulsomes for lipophilic anticancer drug delivery: Development, optimization

and In-vitro drug release kinetic study, Int J App Pharm. 2021;13: 114-21.

Singhvi G, Sing M. Review: In-vitro drug release characterization models. IJPSR 2011; 1: 77-84.

Published

26-08-2021

How to Cite

PATHAK, S., VYAS, S. P., & PANDEY, A. (2021). DEVELOPMENT, CHARACTERIZATION AND IN-VITRO RELEASE KINETIC STUDIES OF IBANDRONATE LOADED CHITOSAN NANOPARTICLES FOR EFFECTIVE MANAGEMENT OF OSTEOPOROSIS. International Journal of Applied Pharmaceutics, 13(6). https://doi.org/10.22159/ijap.2021v13i6.42697

Issue

Section

Original Article(s)